Inactive Instrument

Analyst Reco. Oak Street Health, Inc.

Equities

OSH

US67181A1079

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Global dealmaking sinks to lowest level in over a decade	23-03-31	RE
Wolfe Research Downgrades Oak Street Health to Peer Perform From Outperform	23-03-21	MT
TD Cowen Downgrades Oak Street Health to Market Perform From Outperform, Raises Price Target to $39 From $34	23-03-15	MT
JPMorgan Downgrades Oak Street Health to Neutral From Overweight, Adjusts Price Target to $39 From $35	23-02-23	MT
Bernstein Downgrades Oak Street Health to Market Perform From Outperform, Adjusts Price Target to $39 From $35	23-02-15	MT
Raymond James Downgrades Oak Street Health to Market Perform From Outperform	23-02-10	MT
William Blair Downgrades Oak Street Health to Market Perform From Outperform	23-02-09	MT
Truist Securities Downgrades Oak Street Health to Hold From Buy, Adjusts Price Target to $39 From $32	23-02-09	MT
Canaccord Genuity Downgrades Oak Street Health to Hold From Buy, Adjusts Price Target to $39 From $29	23-02-09	MT
Jefferies Downgrades Oak Street Health to Hold From Buy	23-02-09	MT
Wall St falls as policymakers' comments fan rate hike worries; Alphabet slumps	23-02-08	RE
SVB Securities Adjusts Oak Street Health's Price Target to $39 From $33, Keeps Market Perform Rating	23-02-08	MT
Stifel Downgrades Oak Street Health to Hold From Buy, Keeps Price Target at $39	23-02-08	MT
Evercore ISI Downgrades Oak Street Health to In Line From Outperform, Adjusts Price Target to $39 From $25	23-02-08	MT
Piper Sandler Downgrades Oak Street Health to Neutral From Overweight, Adjusts Price Target to $39 From $47	23-02-08	MT
Raymond James Upgrades Oak Street Health to Outperform From Market Perform, Price Target is $35	23-01-12	MT
SVB Securities Adjusts Oak Street Health's Price Target to $33 From $23, Maintains Market Perform Rating	23-01-10	MT
UBS Adjusts Oak Street Health Price Target to $21 From $28, Maintains Neutral Rating	23-01-06	MT
Raymond James Downgrades Oak Street Health to Market Perform From Outperform	22-11-21	MT
Morgan Stanley Upgrades Oak Street Health to Overweight Rating From Equal-Weight	22-11-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Oak Street Health, Inc.

Equities

OSH

US67181A1079

Analyst Reco.

Filters